Psychedelic frees up depressed brain, study shows

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact investing@albertlabs.com

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

Name*
First Last
Email*
Contact Number*

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

You Might Also Like

Virginia Lawmakers Propose Decriminalizing Psychedelic Mushrooms

First patient in Quebec gets approval from Health Canada for magic mushroom therapy

New UK guidance on real-world data is good news for psychedelics

About Albert Labs